Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin

Molecular Medicine Reports

Volumn 3, Issue 5, 2010, Pages 741-747

  Kang, Sang Yoon ^a   Lee, Sung Jun ^b   Hong, Seung Ho ^c   Chung, Yoon Kyu ^b   Oh, Hyun Soo ^a   Kim, Sug Won ^b   Yim, Dong Jin ^d   Kim, Nam Keun ^d  

^a Kyung Hee University Hospital   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

^c Jeju National University   (South Korea)

^d CHA University   (South Korea)

Author keywords

Basal cell carcinoma; Methylenetetrahydrofolate reductase; Skin; Squamous cell carcinoma; Thymidylate synthase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); THYMIDYLATE SYNTHASE;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; GENE INSERTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

EID: 78049511246     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.329     Document Type: Article

References (37)

1. Mohrenweiser HW, Xi T, Vázquez-Matías J and Jones IM: Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev 11: 1054-1064, 2002.
2. Pogribny IP, Muskhelishvili L, Miller BJ and James SJ: Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. Carcinogenesis 18: 2071-2076, 1997.
3. Dianov GL, Timchenko TV, Sinitsina OI, Kuzminov AV, Medvedev OA and Salganik RI: Repair of uracil residues closely spaced on the opposite strands of plasmid DNA results in double strand break and deletion formation. Mol Gen Genet 225: 448-452, 1991.
4. Robien K and Ulrich CM: 5,10-methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 157: 571-582, 2003.
5. Frosst P, Blom HJ and Milos R: a candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113, 1995.
6. Rozen R: Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetra hydrofolate reductase (MTHFR). Thromb Haemost 78: 523-526, 1997.
7. Weisberg I, Tran P, Chritensen B, Sibani S and Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64: 169-172, 1998.
8. McCully KS: Vascular pathology of homocysteinemia: implication for the pathogenesis of arteriosclerosis. Am J Pathol 56: 111-128, 1969.
9. Fodinger M, Wagner OF, Horl WH and Sunderplassman G: Recent insights into the molecular genetics of the homocysteine metabolism. Kidney Int Suppl 78: S238-S242, 2001.
10. Jakubowski H, Zhang L, Bardequez A and Aviv A: Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implication for atherosclerosis. Circ Res 87: 45-47, 2000.
11. Wang LD, Guo RF, Fan ZM, He X, Gao SS, Guo HQ, Matsuo K, Yin LM and Li JL: Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus 18: 177-184, 2005.
12. Song C, Xing D, Tan W, Wei Q and Lin D: Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61: 3272-3275, 2001. (Pubitemid 32695011)
13. Park KS, Mok JW and Kim JC: The 677C→T mutation in 5,10-methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test 3: 233-236, 1999.
14. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA and Morgan G: Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96: 12810-12815, 1999. (Pubitemid 29513584)
15. Kaneda S, Takeishi K, Ayusawa D, Shimizu K, Seno T and Altman S: Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA. Nucl Acids Res 15: 1259-1270, 1987. (Pubitemid 17012904)
16. Hori T, Ayusawa D, Shimizu K, Koyama H and Seno T: Chromosome breakage induced by thymidylate stress in the thymidylate synthase-negative mutants of mouse FM3A cells. Cancer Res 44: 703-709, 1984. (Pubitemid 14184608)
17. Duthie SJ: Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55: 578-592, 1999.
18. Khanna KK and Jackson SP: DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27: 247-254, 2001. (Pubitemid 32201842)
19. Maeng JH and Yoon JB: The human PTFgamma/SNAP43 gene: structure, chromosomal location, and identification of a VNTR in 5′-UTR. J Biochem 14: 23-27, 1998.
20. Goto Y, Yue L, Yokoi A, Nishimura R, Uehara T, Koizumi S and Saikawa Y: A novel single-nucleotide polymorphism in 3′-untranslated region of the human dihydrofolate reductase gene with enhanced expression. Clin Cancer Res 7: 1952-1956, 2001.
21. Mill J, Asherson P, Browes C, D'Souza U and Craig I: Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114: 975-979, 2002.
22. Moor CH, Meijer H and Lessenden S: Mechanisms of translational control by the 3′ UTR in development and differentiation. Semin Cell Dev Biol 16: 49-58, 2005.
23. Marsh S, McKay JA, Cassidy J and McLeod HL: Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer. Int J Oncol 19: 383-386, 2001.
24. Mandola MV, Stoehlmacher J, Zhang W, Groshen S, Yu MC, Iqbal S, Lens HJ and Ladner RD: A 6 bp polymorphism in the thymidylate syntase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 14: 319-327, 2004. (Pubitemid 38638919)
25. Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM and Potter JD: Searching expressed sequence tag databases: discovery and confirmation of a common polymorphisms in thymidylate syntase gene. Cancer Epidermiol Biomarkers Prev 9: 1381-1385, 2000. (Pubitemid 32044809)
26. Blount BC, Mack MM, Wehr CM, Macgregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB and Ames BN: Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94: 3290-3295, 1997. (Pubitemid 127634978)
27. Ulrich CM, Bigler J, Bostrick R, Fosdick L and Potter JD: Thymidylate synthase promoter polymorphisms, interaction with folate intake, and risk of colorectal adenoma. Cancer Res 62: 3361-3364, 2002. (Pubitemid 34651378)
28. Lightfoot TJ, Skibola CF, Willett EV, Skibola DR, Allan JM and Coppede F: Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 14: 2999-3003, 2005. (Pubitemid 43068838)
29. Zhai X, Gao J, Hu Z, Tang J, Qin J and Wang S: Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis. BMC Cancer 6: 138, 2006.
30. Kealey C, Brown KS, Woodside JV, Young I, Murray L, Boreham CA, McNulty H, Strain JJ, McPartlin J, Scott JM and Whitehead AS: A common insertion/deletion of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrations. Hum Genet 116: 347-353, 2005.
31. Neumann AS, Lyons HJ, Shen H, Liu Z, Shi Q, Sturgis EM, Shete S, Spitz MR, EI-Naggar A, Hong WK and Wei Q: Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer 115: 131-136, 2005. (Pubitemid 40559678)
32. Nelson HH, Kelsey KT, Mott LA and Karagas MR: The XRCC1 Arg399Gln polymorphism, sunburn, and, non-melanoma skin cancer: evidence of gene environment interaction. Cancer Res 62: 152-155, 2002.
33. Vogel U, Hedayati M, Dybdahl M, Grossman L and Nexo BA: Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 22: 899-904, 2001.
34. Winsey SL, Haldar NA, Marsh HP, Bunce M, Marshall SE, Harris AL, Wojnarowska F and Welsh KI: A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60: 5612-5616, 2000.
35. Zhang Z, Liu W, Jia X, Gao Y, Hemminki K and Lindholm B: Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma. Clin Chim Acta 342: 137-143, 2004.
36. Festa F, Kumar R, Sanyal S, Unden B, Nordfors L, Lindholm B, Snellman E, Schalling M, Försti A and Hemminki K: Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutat Res 574: 105-111, 2005.
37. Zhang J, Cui Y, Kuang G, Li Y, Wang N, Wang R, Guo W, Wen D, Wei L, Yu F and Wang S: Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenomacarcinoma. Carcinogenesis 25: 2479-2485, 2004. (Pubitemid 39625190)